Contact This Study Your name* First Your email* Your phone numberYour contact information will be sent to a team atYour contact information will be sent to a team at Your information will be kept confidential and will never be sold or shared with outside vendors.Study TitleA Phase 2 Study to Evaluate the Safety and Biologic Activity of APL- 2 in Patients With IgA Nephropathy, Lupus Nephritis, Primary Membranous Nephropathy, or C3 Glomerulopathy (C3 Glomerulonephritis and Dense Deposit Disease)HiddenStudy Email HiddenStudy Marketing TitleThe Discovery Trial for IgAN, MN, LN, and C3G PatientsHiddenSite NameApellis Investigational SiteHiddenSite LocationMemphis, TN.HiddenUser Role Sign up to get NephCure’s latest updates. SIGN UP Email(Required) PhoneThis field is for validation purposes and should be left unchanged.